USPTO serial 87148237
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William B. Slate
WILLIAM B. SLATE BACHMAN & LAPOINTE, PC900 CHAPEL ST., SUITE 1201NEW HAVEN, CT 06510UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Single- and multiple-layer containers, namely, containers for medical waste, containers especially adapted for the disposal of medical instruments and syringes; single- and multiple-layer pouches, namely, disposable medical sterilization pouches; containers, bags, sacks, sachets and pouches specially designed for holding pharmaceuticals; containers, bags, sacks, sachets and pouches adapted for pharmaceutical purposes, namely, for holding medications, medical devices, and medical supplies; containers, bags, sacks, sachets and pouches featuring a valve or seal specially designed for holding pharmaceuticals; containers, bags, sacks, sachets and pouches featuring a valve or a seal adapted for pharmaceutical purposes, namely, for holding medications, medical devices, and medical supplies | ACTIVE | — |
| 016 | Single- and multiple-layer containers, bags, sacks, and pouches made of paper and cardboard; single- and multiple-layer bags, sacks, and pouches made of plastic for packaging; single- and multiple-layer sachets sold empty for packaging made of paper, cardboard, and plastic; packaging containers, bags, sacks, sachets and pouches of paper with at least one layer of plastic for use as supports for said containers; single- and multiple-layer plastic bags, sacks, sachets and pouches for packaging; layer materials for packaging comprised primarily of paper or having a layer of paper and at least one layer of plastic; packaging containers, bags, sacks, sachets and pouches of paper with at least one layer of plastic for use as supports for said containers, featuring a valve or a seal; single- and multiple-layer plastic bags, sacks, sachets and pouches for packaging featuring a valve or a seal; layer materials for packaging comprised primarily of paper or having a layer of paper and at least one layer of plastic and featuring a valve or a seal; plastic films for industrial, commercial and medical packaging use; plastic films featuring a valve or a seal for industrial, commercial and medical packaging use; packaging bags of plastic for packaging consumer and retail items, cosmetics, pharmaceuticals, medication, medical devices and medical supplies; plastic bags for commercial use manufactured with a barrier resin or a barrier thin layer of glass, ceramic or metallization for chemical and acid resistance, namely, general purpose plastic bags; packaging bags featuring a valve or a seal of plastic for packaging consumer and retail items, cosmetics, pharmaceuticals, medication, medical devices and medical supplies; plastic bags featuring a valve or a seal for commercial use manufactured with a barrier resin or a barrier thin layer of glass, ceramic or metallization for chemical and acid resistance, namely, general purpose plastic bags | ACTIVE | — |
| 017 | Semi-processed plastics in the form of films, sheets or tubes; films and sheets made from polymers and plastics for use in commercial packaging; plastic sheets for use in the manufacture of packaging; non-metal laminates, films and sheets for use in making packaging, namely, packaging for cosmetics, pharmaceuticals, medications, medical devices and medical supplies; laminate materials for use in the manufacture of containers, bags, sacks, sachets and pouches, in the nature of single- and multiple-layer, laminated plastic films for use for packaging; composite materials comprised primarily of plastic having at least one layer of plastic and at least one barrier, in the nature of a vacuum deposited or sputtered thin glass layer, ceramic layer or metallized layer, namely, plastic composite material in the form of sheets, films, and foils for use in manufacturing; plastic strip-shaped or film-shaped materials, namely, single-layer or multiple-layer composite materials comprised primarily of plastic having a layer of plastic and at least one layer of lacquer coatings, for use in the manufacture of containers, bags, sacks, sachets and pouches; semi-processed plastics in the form of films, sheets or tubes featuring a valve or seal; films and sheets made from polymers and plastics, featuring a valve or a seal for use in commercial packaging; plastic sheets featuring a valve or seal for use in the manufacture of packaging; non-metal laminates, films and sheets featuring a valve or a seal for use in making packaging, namely, packaging for cosmetics, pharmaceuticals, medications, medical devices and medical supplies; laminate material featuring a valve or a seal for use in the manufacture of containers, bags, sacks, sachets and pouches, in the nature of single- and multiple-layer, laminated plastic films for use for packaging; composite materials comprised primarily of plastic having at least one layer of plastic and at least one barrier, in the nature of vacuum deposited or sputtered thin glass layer, ceramic layer or metallized layer, further featuring a valve or seal, namely, plastic composite material in the form of sheets, films, and foils for use in manufacturing; plastic strip-shaped or film-shaped materials featuring a valve or a seal, namely, single-layer or multiple-layer composite materials comprised primarily of plastic having a layer of plastic and at least one layer of lacquer coatings, for use in the manufacture of containers, bags, sacks, sachets and pouches | ACTIVE | — |
| 020 | Plastic storage containers, sacks, sachets and pouches for commercial use; non-metal containers, sacks, sachets and pouches sold empty for pharmaceuticals and medication made of plastic for commercial use; containers, sacks, sachets and pouches sold empty for medications for commercial use; packaging containers, sacks, sachets and pouches of plastic for packaging consumer and retail items, cosmetics, pharmaceuticals, medication, medical devices and medical supplies; plastic containers, sacks, sachets and pouches for commercial use manufactured with a barrier resin or a barrier thin layer of glass, ceramic or metallization for chemical and acid resistance, namely, plastic storage containers for commercial or industrial use; plastic storage containers, sacks, sachets and pouches featuring a valve or seal for commercial use; non-metal containers, sacks, sachets and pouches featuring a valve or seal sold empty for pharmaceuticals and medication made of plastic for commercial use; containers, sacks, sachets and pouches featuring a valve or seal for medications sold empty for commercial use; packaging containers, sacks, sachets and pouches featuring a valve or a seal of plastic for packaging consumer and retail items, cosmetics, pharmaceuticals, medication, medical devices and medical supplies; plastic containers, sacks, sachets and pouches featuring a valve or a seal for commercial use manufactured with a barrier resin or a barrier thin layer of glass, ceramic or metallization for chemical and acid resistance, namely, plastic storage containers for commercial or industrial use; single- and multiple-layer pouches for packaging made of plastic; single- and multiple-layer containers made of plastic for packaging; non-metal containers, bags, sacks and pouches sold empty for pharmaceuticals and medication made of paper, cardboard, and plastic for commercial use; non-metal sachets sold empty for pharmaceuticals and medication made of paper, cardboard, and plastic for commercial use; non-metal containers, bags, sacks and pouches featuring a valve or seal sold empty for pharmaceuticals and medication made of paper, cardboard, and plastic for commercial use; non-metal sachets featuring a valve or seal sold empty for pharmaceuticals and medication made of paper, cardboard, and plastic for commercial use | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 19, 2019 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 19, 2019 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 17, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 15, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 15, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 15, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 17, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 22, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 22, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 2, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 17, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 12, 2018 | ALIE | ASSIGNED TO LIE | — |
| Apr 5, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 5, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 5, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 5, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 5, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 31, 2018 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Jan 31, 2018 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Jan 31, 2018 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Jan 24, 2018 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jan 23, 2018 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 3, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 3, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 3, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 3, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 3, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 9, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 9, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 9, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 4, 2017 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 3, 2017 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 13, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 8, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 7, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 7, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 9, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 9, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 9, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 2, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 30, 2016 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Aug 29, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 26, 2016 | NWAP | NEW APPLICATION ENTERED | — |